Also, the compound potentiated the expression of immune factors, IL‐2‐R and GM‐CSF, known to be associated with optimal host anti‐cancer immune responses and their presence is correlated with good prognosis.23, 26 RANCE‐1’s inhibitory capacities toward 5 key growth factors also adds to its therapeutic potential. The gene discussed is CSF2; the disease is cancer.